CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Testing Devices +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03761394
NCT03761394N/ACompleted
CompareCT.gov

Smartwatch Monitoring for Atrial Fibrillation After Stroke

University of Massachusetts, Worcester·interventional·Posted Dec 3, 2018·Updated Nov 18, 2023

In Brief

A clinical study evaluating Testing Devices, Cardea Solo by Cardiac Insight, and 1 other intervention for Stroke and Atrial Fibrillation. Completed, enrolled 120 participants across 1 site.

Detailed Summary

The goal of this research study is to develop a smartphone application capable of monitoring paroxysmal atrial fibrillation (pAF) in people who have survived a stroke or transient ischemic attack (TIA) or people who are at risk for a stroke and are age 50 and older. The study team plans to develop a highly effective and easy to use cardiovascular surveillance system to monitor patients for pAF on a nearly continuous basis. People involved in the development of this system include patients, their caregivers, health care providers, and computer programmers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Atrial Fibrillation
CountriesUnited States
CollaboratorsUniversity of Connecticut, Northeastern University, Brigham and Women's Hospital, National Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 3, 2018
Enrollment StartSep 3, 2019
Primary CompletionSep 20, 2021
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 7.6 years ago

Interventions

Testing Devicesdevice

Pulsewatch system testing application on smartphone with smartwatch.

Cardea Solo by Cardiac Insightdevice

Gold-standard cardiac monitor for comparison of testing devices.

Kardia Mobile by AliveCordevice

Mobile ECG device for comparison of testing devices during the extended use period.